Analyst Price Targets — HALO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 19, 2026 1:43 pm | — | Morgan Stanley | $94.00 | $72.19 | TheFly | Halozyme price target raised to $94 from $78 at Morgan Stanley |
| February 19, 2026 11:28 am | — | Wells Fargo | $75.00 | $73.23 | TheFly | Halozyme price target raised to $75 from $65 at Wells Fargo |
| January 8, 2026 12:39 pm | — | Morgan Stanley | $75.00 | $75.11 | TheFly | Halozyme price target lowered to $75 from $79 at Morgan Stanley |
| December 4, 2025 11:55 am | — | UBS | $56.00 | $64.66 | TheFly | Halozyme downgraded to Sell from Neutral at Goldman Sachs |
| December 4, 2025 11:51 am | Corinne Jenkins | Goldman Sachs | $56.00 | $62.82 | StreetInsider | Goldman Sachs Downgrades Halozyme Therapeutics (HALO) to Sell 'as we approach peak revenue' |
| November 4, 2025 10:43 am | — | JMP Securities | $92.00 | $66.20 | TheFly | Halozyme price target raised to $92 from $91 at Citizens JMP |
| October 20, 2025 11:34 am | — | Morgan Stanley | $79.00 | $67.03 | TheFly | Halozyme price target lowered to $79 from $80 at Morgan Stanley |
| October 14, 2025 5:06 pm | — | Leerink Partners | $70.00 | $66.65 | TheFly | Halozyme upgraded at Leerink on lower-than-feared Part B exposure |
| October 2, 2025 10:15 am | — | H.C. Wainwright | $90.00 | $74.94 | TheFly | Halozyme price target raised to $90 from $85 at H.C. Wainwright |
| May 14, 2025 8:46 am | Sean Laaman | Morgan Stanley | $62.00 | $66.58 | TheFly | Halozyme downgraded to Equal Weight from Overweight at Morgan Stanley |
Latest News for HALO
Halozyme Therapeutics, Inc. (HALO) Presents at TD Cowen 46th Annual Health Care Conference Transcript
SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, President and Chief Executive Officer, is scheduled to present and host investor meetings at the following investor conferences: Event: TD Cowen 46th Annual Healthcare Conference Format: Fireside Chat and 1x1 Meetings Presentation Date: Tuesday, March 3, 2026 Presentation Time:…
ASTS lands a $30 million Space Development Agency contract to deploy BlueBird LEO satellites, advancing direct-to-device defense communications.
150-Patient, Triple-Blinded, Sham-Controlled Study Designed to be Executed in Collaboration with Lindus Health to Support Future FDA Submission for Drug-Free Insomnia Treatment
MIDLAND, Texas--(BUSINESS WIRE)---- $ASTS #AST--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, today announced that it has entered into an agreement with the United States Space Development Agency (SDA) for the Europa Track 2…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.